Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse

Hepatology

Volumn 39, Issue 6, 2004, Pages 1583-1592

  Palmer, Jeremy M ^a,b   Robe, Amanda J ^a   Burt, Alastair D ^a   Kirby, John A ^a   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BIOTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PYRUVATE DEHYDROGENASE COMPLEX;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOTINYLATION; CONTROLLED STUDY; COVALENT MODIFICATION; ENZYME MODIFICATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS; IMMUNE SERA; IMMUNE TOLERANCE; LIVER; MICE; PYRUVATE DEHYDROGENASE COMPLEX; T-LYMPHOCYTES;

EID: 2542627510     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20248     Document Type: Article

References (44)

1. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
2. Nossal GJ. Negative selection of lymphocytes. Cell 1994;76:229-239.
3. Ramsdell F, Fowlkes BJ. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 1990;248:1342-1348.
4. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 1990;144:16-22.
5. Honeyman MC, Cram DS, Harrison LC. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med 1993;177:535-540.
6. Tandon N, Freeman MA, Weetman AP. T cell responses to synthetic TSH receptor peptides in Graves' disease. Clin Exp Immunol 1992;89:468-473.
7. Willcox N, Baggi F, Batocchi AP, Beeson D, Harcourt G, Hawke S, et al. Approaches for studying the pathogenic T cells in autoimmune patients. Ann NY Acad Sci 1993;681:219-237.
8. Doyle HA, Mamula MJ. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001;22:443-449.
9. Doyle HA, Mamula MJ. Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 2002;14:244-249.
10. Kimber I, Dearman RJ. Immunologic basis for autoimmunity and the potential influences of xenobiotics. Toxicol Lett 2002;127:77-81.
11. Bigazzi PE. Autoimmunity caused by xenobiotics. Toxicology 1997;119:1-21.
12. Yeaman SJ, Kirby JA, Jones DE. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000;174:238-249.
13. Palmer JM, Diamond AG, Yeaman SJ, Bassendine MF, Jones DE. T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC). Clin Exp Immunol 1999;116:133-139.
14. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. HEPATOLOGY 1997;26:1399-1405.
15. Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002;195:113-123.
16. Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002;109:1231-1240.
17. Jones DEJ. Pathogenesis of primary biliary cirrhosis. J Hepatol 2003;39:639-648.
18. Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 2002;1:37-42.
19. Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, et al. The aetiology of primary bilairy cirrhosis: connecting xenobiotics to antimitochondrial antibodies by ab initio quantum chemistry. HEPATOLOGY 2001;34:341A.
20. Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167:2956-2963.
21. Leung PS, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003;170:5326-5332.
22. Krams SM, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. HEPATOLOGY 1989;9:411-416.
23. Klein R, Wiebel M, Engelhart S, Berg PA. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol 1993;92:308-316.
24. Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 1995;35:473-485.
25. Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD, Yeaman SJ, et al. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 2000;20:351-356.
26. Robe AJ, Palmer JM, Kirby J, Jones DEJ. No role for autoreactive antibody in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex, the autoantigen in primary biliary cirrhosis. Hepatology 2001;34:121A.
27. Quinn J, Diamond AG, Palmer JM, Bassendine MF, James OF, Yeaman SJ. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993;18:1384-1391.
28. Sansaki M, Nakanuma Y, Gershwin ME, Demetris AJ, Wanless IR, Thung SN, et al. Biotin-related proteins of 70 and 72 kDa in gallbladder bile in primary biliary cirrhosis. Hepatology Research 1999;14:154-160.
29. Stanley CJ, Perham RN. Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 1980;191:147-154.
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
31. Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. HEPATOLOGY 1999;30:65-70.
32. Jones DE, Palmer JM, Bennett K, Robe AJ, Yeaman SJ, Robertson H, et al. Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Lab Invest 2002;82:211-219.
33. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1986;86:83-87.
34. Macdonald RA, Hosking CS, Jones CL. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 1988;106:191-194.
35. Palmer JM, Jones DE, Quinn J, McHugh A, Yeaman SJ. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. HEPATOLOGY 1999;30:21-26.
36. Reche P, Perham RN. Structure and selectivity in post-translational modification: attaching the biotinyl-lysine and lipoyl-lysine swinging arms in multifunctional enzymes. Embo J 1999;18:2673-2682.
37. Mamula MJ. Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol Rev 1998;164:231-239.
38. Jones DE, Palmer JM, Burt AD, Walker C, Robe AJ, Kirby JA. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. HEPATOLOGY 2002;36:679-686.
39. Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well-defined cohort. HEPATOLOGY 2001;34:1083-1088.
40. Powell JJ, Van de Water J, Gershwin ME. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 1999;107:667-672.
41. Van Loveren H, Vos JG, Germolec D, Simeonova PP, Eijkemanns G, McMichael AJ. Epidemiologic associations between occupational and environmental exposures and autoimmune disease: report of a meeting to explore current evidence and identify research needs. Int J Hyg Environ Health 2001;203:483-495.
42. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991;173:1433-1439.
43. Mamula MJ, Lin RH, Janeway CA Jr, Hardin JA. Breaking T cell tolerance with oreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-795.
44. Constant SL. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 1999;162:5695-5703.